Business Context and Reporting Period
This Form 6-K filing by YD Bio Limited covers the month of November 2025. The report details significant changes to the composition of the Board of Directors and the Audit Committee, specifically the resignation of the former Audit Committee Chair and the appointment of a successor.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes
- Resignation: Joseph Hing Lung Tseng resigned as an independent Director and Chairman of the Audit Committee on October 27, 2025, for personal reasons unrelated to any dispute with the Company.
- Appointment: Jerry Yin-Chia Lee was appointed as an independent Director and Chairman of the Audit Committee on November 13, 2025, effective immediately.
- Independence Status: On November 13, 2025, the Company was notified that Ms. Jan Hall no longer qualifies as an independent director.
Outlook, Risks, and Contingencies
Nasdaq Compliance Risk: Due to Ms. Hall's loss of independent director status, the Company is subject to Nasdaq Listing Rule 5605(c)(4)(B). The Company has 180 days from the date of notice to regain compliance with Nasdaq Listing Rule 5605(c)(2).
Management Commentary: The Board believes Mr. Lee is qualified to serve due to his extensive experience advising early-stage biotech and healthcare companies. There are no family relationships or undisclosed material interests between Mr. Lee and other directors or officers.
Key Facts for Investor Verification
- Verify the Company's plan and timeline to regain compliance with Nasdaq Listing Rule 5605(c)(2) regarding the independence of its Audit Committee.
- Confirm the effective date of Jerry Yin-Chia Lee's appointment as Audit Committee Chair (November 13, 2025).
- Review the Company's next periodic financial report for actual financial performance metrics, as none are included in this filing.